Begin main content

CDR Update 132

December 12, 2017
See CDR Update 132 for important news and information regarding the CADTH Common Drug Review.

New at CADTH — December 2017

December 11, 2017
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.

Calls for Patient Input: Darunavir/cobicistat/emtricitabine/tenofovir alafenamide

November 24, 2017
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website. Darunavir/cobicistat/emtricitabine/tenofovir a...

Calls for Patient Input: Dolutegravir and rilpivirine

November 23, 2017
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website. Dolutegravir and rilpivirine Brand name Generi...

Calls for Patient Input: Iluvien and Probuphine

November 22, 2017
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website. Iluvien Brand name Generic name Manufacturer I...